440102-93-2

Basic information

• Product Name: 2-methyl-N~1~-(4-nitrophenyl)propane-1,2-diamine
• Synonyms: 1,2-propanediamine, 2-methyl-N< sup> 1< /sup> -(4-nitrophenyl)-; 2-Methyl-N< sup> 1< /sup> -(4-nitrophenyl)propan-1,2-diamin; 2-methyl-N< sup> 1< /sup> -(4-nitrophenyl)propane-1,2-diamine
• CAS NO: 440102-93-2
• Molecular Formula: C₁₀H₁₅N₃O₂
• Molecular Weight: 209.245
• Mol File: 440102-93-2.mol

Chemical Properties

• Boiling Point: 374.5°C at 760 mmHg
• Flash Point: 180.3°C
• Density: 1.202g/cm³
• Vapor Pressure: 8.34E-06mmHg at 25°C
• Refractive Index: 1.603
• CAS DataBase Reference: 2-methyl-N~1~-(4-nitrophenyl)propane-1,2-diamine(CAS DataBase Reference)
• NIST Chemistry Reference: 2-methyl-N~1~-(4-nitrophenyl)propane-1,2-diamine(440102-93-2)
• EPA Substance Registry System: 2-methyl-N~1~-(4-nitrophenyl)propane-1,2-diamine(440102-93-2)

Safety Data

• Hazardous Substances Data: 440102-93-2(Hazardous Substances Data)

Upstream product

• 350-46-9 4-Fluoronitrobenzene 
• 811-93-8 1,1-dimethylethylenediamine 
• 100-00-5 4-chlorobenzonitrile 

Relevant articles and documents

Palladium-catalyzed enantioselective C-H activation of aliphatic amines using chiral anionic BINOL-phosphoric acid ligands

The design of an enantioselective Pd(II)-catalyzed C-H amination reaction is described. The use of a chiral BINOL phosphoric acid ligand enables the conversion of readily available amines into synthetically valuable aziridines in high enantiomeric ratios.

Selective Reductive Elimination at Alkyl Palladium(IV) by Dissociative Ligand Ionization: Catalytic C(sp3)?H Amination to Azetidines

A palladium(II)-catalyzed γ-C?H amination of cyclic alkyl amines to deliver highly substituted azetidines is reported. The use of a benziodoxole tosylate oxidant in combination with AgOAc was found to be crucial for controlling a selective reductive elimination pathway to the azetidines. The process is tolerant of a range of functional groups, including structural features derived from chiral α-amino alcohols, and leads to the diastereoselective formation of enantiopure azetidines.

P2X4 RECEPTOR ANTAGONIST

The present invention relates to a compound represented by the following general formula (II), wherein, in the formula, R1a to R6a represent hydrogen atom, an alkyl group having 1 to 8 carbon atoms, and the like, Xa repres

Structure-activity relationship of quinoline derivatives as potent and selective α2c-adrenoceptor antagonists

Starting from two acridine compounds identified in a high-throughput screening campaign (1 and 2, Table 1), a series of 4-aminoquinolines was synthesized and tested for their properties on the human α2- adrenoceptor subtypes (α2A, α2B, and α2C). A number of compounds with good antagonist potencies against the α2C-adrenoceptor and excellent subtype selectivities over the other two subtypes were discovered. For example, (R)-{4-[4-(3,4-dimethylpiperazin-1-yl)phenylamino]quinolin-3-yl}methanol 6j had an antagonist potency of 8.5 nM against, and a subtype selectivity of more than 200-fold for, the α2c-adrenoceptor. Investigation of the structure-activity relationship identified a number of structural features, the most critical of which was an absolute need for a substituent in the 3-position of the quinoline ring. The 3-position on the piperazine ring was also found to play an appreciable role, as substitutions in that position exerted a significant and stereospecific beneficial effect on the α2C- adrenoceptor affinity and potency. Replacing the piperazine ring proved difficult, with 1,4-diazepanes representing the only viable alternative.

DIPEPTIDYL PEPTIDASE IV INHIBITOR

A compound represented by general formula (I):A-B-D whereinA represents a substituted or unsubstituted 1-pyrrolidinyl group, a substituted or unsubstituted 3-thiazolidinyl group, a substituted or unsubstituted 1-oxo-3-thiazolidinyl group, or the like;B r